No image available
Drug-resistant TB may have hit its sell-by date
The first promising tuberculosis (TB) drug in almost 40 years could be the best yet, according to the <i>Science and Development Network</i>. This is good news for Southern Africa, which is home to large numbers of people suffering from TB as a result of HIV/Aids. Animal tests indicate that the drug could also treat the disease faster, reducing costs, according to new research.
